In almost all of these studies, the over-expression of HMGB1 has been documented in tissues by measuring mRNA levels via in situ hybridization or immunohistochemical analysis [7-10,15-17], but there is little information about the corresponding serological activity of HMGB1 and the progression of GC. Here, HMGB1 is linked to gastric cancer.